Mayumi Tamura

Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases

H. Yamana, S. Shichijo, K. Itoh, 2001, European journal of immunology.

Peptide Vaccination for Patients With Melanoma and Other Types of Cancer Based on Pre-existing Peptide-Specific Cytotoxic T-Lymphocyte Precursors in the Periphery

H. Yamana, K. Azuma, K. Itoh, 2003, Journal of immunotherapy.

Identification of Cyclophilin B‐derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen‐A2‐restricted and Tumor‐specific Cytotoxic T Lymphocytes

Masaaki Ito, S. Shichijo, K. Itoh, 2001, Japanese journal of cancer research : Gann.

Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.

T. Ide, M. Sata, K. Itoh, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Phase 1 Clinical Study of Cyclophilin B Peptide Vaccine for Patients With Lung Cancer

H. Yamana, M. Kawamoto, K. Itoh, 2002, Journal of immunotherapy.

A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33

T. Ide, M. Sata, K. Itoh, 2007, Cancer Immunology, Immunotherapy.

Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.

T. Ide, M. Sata, K. Itoh, 2007, Vaccine.

HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patients.

K. Azuma, S. Shichijo, K. Itoh, 2004, International journal of oncology.

Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.

K. Itoh, T. Kamura, S. Matsueda, 2005, International journal of oncology.